Vimarsana
Biggest News Aggregation in the World

Page 2 - Lead Optimisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Optimisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Optimisation Today - Breaking & Trending Today

EQS-News: Proteros biostructures GmbH: Proteros receives minority investment from private equity firm Inflexion - Vimarsana News

EQS-News: Proteros biostructures GmbH: Proteros receives minority investment from private equity firm Inflexion

EQS-News: Proteros biostructures GmbH / Key word(s): Financing Proteros receives minority investment from private equity firm Inflexion 09.01.2023 / 10:00 CET/CEST The issuer is

EQS-News: Proteros biostructures GmbH: Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases - Vimarsana News

EQS-News: Proteros biostructures GmbH: Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

EQS-News: Proteros biostructures GmbH / Key word(s): Alliance Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases 25.10.2022

Adrestia Therapeutics: Adrestia appoints Head of Chemistry and initiates multi-target partnership with Proteros to discover first-in-class drugs for intractable genetic diseases - Vimarsana News

Adrestia Therapeutics: Adrestia appoints Head of Chemistry and initiates multi-target partnership with Proteros to discover first-in-class drugs for intractable genetic diseases

Drug discovery leader Dr James Osborne brings strong track record of delivering drug candidates for oncology and CNS disorders Proteros selected for its cutting-edge structure-based drug